Policy newsAMI's policy team is one of the most active in the sector - read the latest news here.
AMI welcomes prospect of Horizon re-entry following Brexit deal
Applied Microbiology International (AMI) has welcomed the EU Commission President’s recent mention of starting work on associating the UK to the €100bn (£88.6bn) Horizon Europe programme.
Regulatory pathway needs to be developed to make the most of phages: AMI
A regulatory pathway needs to be developed if the UK is to reap the benefits of bacteriophage therapy, Applied Microbiology International (AMI) has warned.
AMI pitches Government to develop pathway to phage therapy
Applied Microbiology International is urging the UK Government to launch an inquiry to explore the regulatory barriers and opportunities for bacteriophage therapy in the UK, in order to explore their potential as an alternative or addition to conventional antimicrobial drugs.
AMI’s pitch on bacteriophages is winner of My Science Inquiry
Applied Microbiology International’s pitch to explore bacteriophages as an alternative to antimicrobial drugs has been selected by the Commons Science and Technology Committee as the winner of the My Science inquiry.
AMI holds roundtable to discuss UK's AMR 5-year National Action Plan
On 29 November 2022, AMI held a roundtable with policy experts on the next steps for the UK with regards to AMR.